“ambrx” Archives

Entry Author Date Location
Ambrx CEO Steve Kaldor Departs 07/12/10 San Diego
The 20-Year Outlook for San Diego Life Sciences: Sold Out? Not Anymore 03/15/10 San Diego
The 20-Year Future of San Diego Biotech, Coming March 31 03/09/10 San Diego
What Will San Diego’s Biotech Hub Look Like in 20 Years? Xconomy Event Takes Long View 02/16/10 San Diego
Biogen Idec CEO Stepping Down, Ambrx Focuses on Empowered Antibodies, Intellikine Testing First Drug Candidate, & More San Diego Life Sciences News 01/07/10 San Diego
Ambrx, Saying Thanks to its Rivals, Rides Wave of Interest in “Empowered” Antibodies 01/06/10 San Diego
Swine Flu Could Benefit Some Biomedical Companies, Local Biotechs Are Looking Healthier, Arena Happy With Obesity Drug Results, & More San Diego Life Sciences News 09/24/09 San Diego
Ambrx Strikes Deal With Wyeth (Soon-to-be Pfizer) to Make Antibody Drugs 09/18/09 San Diego
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets 08/18/09 San Diego
Wireless Medicine Gets $45M Booster Shot, Arena’s Weight-Loss Trial Underwhelms Wall Street, Venter’s Synthetic Genomics About to Ramp Up, & Other San Diego BizTech News 04/06/09 San Diego
Ambrx Gets $10 Million in Venture Round 04/01/09 San Diego
Biogen Idec, Extending Life of its Top-Selling Drug, Eyes Longer-Lasting Shot for MS 03/27/09 Boston
Biotech CEOs Discuss the Virtues of Going Virtual 03/26/09 San Diego
Pacira and Histogen Disclose Layoffs, Optimer Advances Diarrhea Drug, Torrey Path Comes to Town, & More SD BizTech 03/02/09 San Diego
UW’s Gardasil Windfall, Cell Therapeutics Unloads Zevalin, Trubion Cuts Jobs, & More Seattle-Area Life Sciences News 02/26/09 Seattle
Ambrx Nails Down Partnership with Merck KGaA to Develop Multiple Sclerosis Drug 02/24/09 San Diego
Ambrx Aims to Create New Breed of Custom-Built Biotech Drugs 12/08/08 San Diego
Ambrx Garners $28,364,000 New Round 06/30/06 San Diego
Page 2 of 2 « previous page